SIRT1 and Hepatic steatosis: The specific deletion of hepatic Sirt1 impairs the fatty acid β-oxidation pathway, thereby heightening the susceptibility of mice to HFD-induced dyslipidemia, hepatic steatosis, inflammation, and ER stress [39,40].